Covered recipient · General Payments record
MAJA MARINKOVIC
Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology
General Payments · PY2018–2024
$8,337.27
- Reported across 144 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,066.08 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $231.54 | 10 |
| TOLMAR, INC. | $206.34 | 2 |
| Tandem Diabetes Care, Inc. | $151.31 | 2 |
| ABBVIE INC. | $134.55 | 10 |
| Ascendis Pharma Inc | $121.67 | 2 |
| Novo Nordisk AS | $85.93 | 4 |
| Azurity Pharmaceuticals, Inc. | $82.85 | 4 |
| Kyowa Kirin, Inc. | $26.64 | 1 |
| Eton Pharmaceuticals, Inc. | $25.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020212023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $0.46 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104966906 | CMS |
| ABBVIE INC. | $22.42 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104966908 | CMS |
| ABBVIE INC. | $21.17 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104966910 | CMS |
| ABBVIE INC. | $23.56 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104966912 | CMS |
| ABBVIE INC. | $20.92 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104966914 | CMS |
| ABBVIE INC. | $0.28 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104966916 | CMS |
| ABBVIE INC. | $26.62 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104966918 | CMS |
| ABBVIE INC. | $0.69 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104966920 | CMS |
| ABBVIE INC. | $18.24 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104966922 | CMS |
| ABBVIE INC. | $0.19 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104966924 | CMS |
| Ascendis Pharma Inc | $91.78 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133843892 | CMS |
| Ascendis Pharma Inc | $29.89 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133847288 | CMS |
| Azurity Pharmaceuticals, Inc. | $18.36 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134009463 | CMS |
| Azurity Pharmaceuticals, Inc. | $20.38 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134009465 | CMS |
| Azurity Pharmaceuticals, Inc. | $20.43 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134009467 | CMS |
| Azurity Pharmaceuticals, Inc. | $23.68 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134009469 | CMS |
| Dexcom, Inc. | $22.67 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153318326 | CMS |
| Dexcom, Inc. | $17.51 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153318328 | CMS |
| Dexcom, Inc. | $0.79 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153318330 | CMS |
| Dexcom, Inc. | $24.09 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153318332 | CMS |
| Dexcom, Inc. | $17.68 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153318334 | CMS |
| Dexcom, Inc. | $23.57 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153318336 | CMS |
| Dexcom, Inc. | $20.09 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153318340 | CMS |
| Dexcom, Inc. | $41.55 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153318338 | CMS |
| Dexcom, Inc. | $34.44 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153318342 | CMS |
| Dexcom, Inc. | $29.15 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153318344 | CMS |
| Eton Pharmaceuticals, Inc. | $25.25 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108021314 | CMS |
| Kyowa Kirin, Inc. | $26.64 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127036288 | CMS |
| Novo Nordisk Inc | $20.01 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097196125 | CMS |
| Novo Nordisk Inc | $23.52 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096925746 | CMS |
| Novo Nordisk Inc | $20.50 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097577074 | CMS |
| Novo Nordisk Inc | $21.90 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097491772 | CMS |
| Tandem Diabetes Care, Inc. | $21.58 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138751673 | CMS |
| Tandem Diabetes Care, Inc. | $129.73 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138751699 | CMS |
| Tolmar, Inc. | $175.84 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138711090 | CMS |
| Tolmar, Inc. | $30.50 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138711092 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.